Alpha Windward’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpha Windward’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,032	Closed	-$281K	–	349
2020 Q3	$281K	Hold	1,032	–	–	0.2%	217
2020 Q2	$300K	Sell	1,032 -124	-11%	-$33.6K	0.23%	201
2020 Q1	$275K	Sell	1,156 -7	-0.6%	-$1.61K	0.24%	166
2019 Q4	$255K	Buy	1,163 +689	+145%	+$139K	0.16%	237
2019 Q3	$80K	Hold	474	–	–	0.05%	287
2019 Q2	$79K	Buy	474 +6	+1%	+$1.05K	0.05%	297
2019 Q1	$86K	Hold	468	–	–	0.06%	291
2018 Q4	$78K	Sell	468 -15	-3%	-$2.6K	0.06%	285
2018 Q3	$93K	Sell	483 -47	-9%	-$8.37K	0.06%	291
2018 Q2	$90K	Buy	530 +47	+10%	+$7.29K	0.06%	294
2018 Q1	$79K	Hold	483	–	–	0.05%	293
2017 Q4	$72K	Sell	483 -117	-20%	-$17.3K	0.04%	296
2017 Q3	$91K	Hold	600	–	–	0.06%	290
2017 Q2	$77K	Buy	+600	New	+$72.2K	0.05%	300
2016 Q2	–	Sell	-412	Closed	-$33K	–	465
2016 Q1	$33K	Hold	412	–	–	0.02%	336
2015 Q4	$52K	Buy	+412	New	+$49.7K	0.04%	297

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Alpha Windward's VRTX Position: Q4 2020 in Review

Alpha Windward sold out of Vertex Pharmaceuticals (VRTX) in Q4 2020, closing a stake of 1,032 shares — an estimated $281K sold.

Alpha Windward first reported a position in VRTX in Q4 2015 and held it in 16 quarters. The position peaked at $300K in Q2 2020. 970 funds tracked by Wall St. Rank hold VRTX as of Q4 2020.

Alpha Windward reported no remaining Vertex Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Alpha Windward sold 1,032 Vertex Pharmaceuticals shares in Q4 2020, an estimated $281K.
Alpha Windward first reported a position in Vertex Pharmaceuticals in Q4 2015 and held it in 16 quarters.
Alpha Windward's Vertex Pharmaceuticals position peaked at $300K in Q2 2020.
970 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.